Mr. Grothman (for himself, Ms. Bonamici, Mr. Bilirakis, Mr. Fitzpatrick, Mr. Morelle, Ms. Matsui, Ms. Brownley, Ms. Moore of Wisconsin, Mr. Davis of North Carolina, Ms. Davids of Kansas, and Mr. Wilson of South Carolina) introduced the following bill; which was referred to the Committee on Education and Workforce
To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.
Suzanne Bonamici
(OR); Gus M. Bilirakis
(FL); Brian K. Fitzpatrick
(PA); Joseph D. Morelle
(NY); Doris O. Matsui
(CA); Julia Brownley
(CA); Gwen Moore
(WI); Donald G. Davis
(NC); Sharice Davids
(KS); Joe Wilson
(SC)
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Cancer Drug Parity Act of 2025. H.R. 4101. 119th
Cong., 1st
sess., Introduced in House June 24, 2025. https://www.govinfo.gov/app/details/BILLS-119hr4101ih.
APA
Congress, House of Representatives (2025, June 24). Cancer Drug Parity Act of 2025 (H.R. 4101 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr4101ih.
MLA
United States, Congress, House of Representatives. Cancer Drug Parity Act of 2025. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr4101ih. 119th Congress, H.R. 4101, Introduced in House 24 Jun. 2025.
Bluebook
H.R.4101 - 119th Congress (2025-2026): Cancer Drug Parity Act of 2025, H.R.4101, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119hr4101ih.
